From June 24 to 26, 2025, the world-renowned 23rd World Pharmaceutical Ingredients China Exhibition (CPHI China 2025) was grandly held at the Shanghai New International Expo Center. As a high-quality enterprise in the field of domestic pharmaceutical intermediates and fine chemicals, DYC Group brought a number of core products and solutions to the exhibition, and had in-depth face-to-face exchanges with many professional audiences and peer companies at home and abroad. The exhibition ended successfully and was fruitful.
At this exhibition, DYC Group focused on displaying peptide compounds, bio-buffers, food additives, and pharma-grade hard fat. The booth was very popular, with an endless stream of visitors coming to inquire. Many international customers showed great interest in DYC's products and expressed their intention to further cooperate.
During the exhibition, DYC Group had in-depth exchanges with customer representatives and industry experts from Europe, America, Southeast Asia, the Middle East, and other countries and regions, and conducted extensive discussions on product performance, customized services, international registration support, and other topics, laying a solid foundation for subsequent business expansion. At the same time, DYC Group also took advantage of the exhibition platform to further understand industry dynamics and cutting-edge trends, continuing to optimize its global market layout.
This exhibition was not only a comprehensive display of the brand and technology, but also a valuable opportunity to discuss the future and pursue common development with industry peers. DYC Group will continue to uphold the concept of "establishing a business with integrity, technological innovation, and win-win cooperation," deepen its industry efforts, keep forging ahead, provide global customers with better products and services, and contribute to the high-quality development of the pharmaceutical and health industries.
